Latest California Healthline Stories
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Insulin’s Steep Price Leads To Deadly Rationing
Alec Raeshawn Smith was 23 when diagnosed with Type 1 diabetes, and 26 when he died. He couldn’t afford $1,300 per month for his insulin and other diabetes supplies. So he tried to stretch the doses.
As Treatable As Diabetes? Lawmakers Push New Ways To Stem Opioid Addiction
California lawmakers approved 14 measures to address the opioid crisis, including one that requires health plans to cover medication-based treatments for opioid addiction without requiring pre-authorization. Gov. Jerry Brown has until the end of September to approve or reject the proposals.
The High Cost Of Hope: When The Parallel Interests Of Pharma And Families Collide
Desperate for help in finding a lifesaving drug for a fatal genetic disease, families banded together to fund early research and then worked with drug companies on clinical trials and marketing. Yet, this small patient advocacy group is stunned by pharma’s pricing.
States Looking To Tax Opioids Pin Hopes On November Elections
At least 11 states are going to try to tax opioids despite pushback from pharmaceutical companies.
Rudy Giuliani’s Consulting Firm Had Hand In Halting Florida’s Opioid Investigation
Post-9/11, Giuliani Partners helped craft a plan that put a halt to a probe into Purdue’s marketing of OxyContin.
Podcast: KHN’s ‘What The Health?’ Ask Us Anything!
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Anna Edney of Bloomberg News, Margot Sanger-Katz of The New York Times and Joanne Kenen of Politico answer listeners’ questions about health policy and politics.
CalPERS Health Chief Wields The Power Of Data To Tame Costs
Liana Bailey-Crimmins brings her information-technology expertise to CalPERS’ health division, aiming to curtail spending on otherwise costly procedures and drugs.
Purdue Pharma’s Sales Pitch Downplayed Risks Of Opioid Addiction
Through a widely circulated brochure and a videotape of testimonials, the maker of OxyContin stressed patients’ right to opioid treatment for pain.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.